EMERGENT BIOSOLUTIONS INC. Deferred Tax Assets, Operating Loss Carryforwards
EMERGENT BIOSOLUTIONS INC. (EBS) had Deferred Tax Assets, Operating Loss Carryforwards of $10.70 million as of 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2019-02-22
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards $10.70M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.60M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $1.60M.
- 2016-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.13M.
- 2015-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.39M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2018-12-31 | $10.70M 10-K · filed 2019-02-22 | |
| 2017-12-31 | $1.60M 10-K · filed 2019-02-22 | $1.60M 10-K · filed 2018-02-23 |
| 2016-12-31 | $4.13M 10-K · filed 2018-02-23 | |
| 2015-12-31 | $5.39M 10-K · filed 2017-02-28 | |
| 2014-12-31 | $8.49M 10-K · filed 2016-02-29 | $20.53M 10-K · filed 2015-03-09 |
| 2013-12-31 | $23.26M 10-K · filed 2015-03-09 | |
| 2012-12-31 | $26.10M 10-K · filed 2014-03-10 | |
| 2011-12-31 | $28.62M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |